Full Text
Full text is available in PDF
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects
Author(s):
1Baqiyatallah Research Center for Gastroenterology and Liver Disease, [email protected], IR-Iran
*Corresponding Author: Baqiyatallah Research Center for Gastroenterology and Liver Disease, [email protected], IR-Iran. Tel: +98 21 8126 2072. Fax: +98 21 8126 2072. Email: [email protected]
Published online:Sep 30, 2010
Article type:Letter
Received:Apr 19, 2010
Accepted:Apr 26, 2010
How to Cite:Khedmat H. Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects. Hepat Mon. 2010;10(3):. doi:
Abstract
This article does not have abstract.
Keywords
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Sep
2010
Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients
Frank Tacke
Tacke F. Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients. Hepat Mon. 2010;10(3):. doi:
30
Sep
2010
Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
Valli De Re
Re V. Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives. Hepat Mon. 2010;10(3):. doi:
30
Sep
2004
Commentaries and points of view 2
Kamran Bagheri Lankarani,
Seyed Moayed Alavian
Bagheri Lankarani K, Alavian SM. Commentaries and points of view 2. Hepat Mon. 2004;4(8):e93016. doi:
30
Jun
2010
The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis
Seyed Moayed Alavian,
Bita Behnava,
Seyed Vahid Tabatabaei
Alavian S, Behnava B, Tabatabaei S. The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis. Hepat Mon. 2010;10(2):. doi:
22
Nov
2014
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
Mohamad Amin Pourhoseingholi,
Sara Ashtari,
Seyed Moayed Alavian
Pourhoseingholi MA, Ashtari S, Alavian SM. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?. Hepat Mon. 2014;14(11):25540. doi: https://doi.org/10.5812/hepatmon.25540
Download PDF306.58 KB
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Related Articles